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Chimeric proteins containing a cellulose-binding module (CBM) and an adhesion peptide (RGD or
GRGDY) were produced and used to improve the adhesion of human microvascular endothelial cells
(HMEC) to bacterial cellulose (BC). The effect of these proteins on the HMEC–BC interaction was studied.
The results obtained demonstrated that recombinant proteins containing adhesion sequences were able
to signiﬁcantly increase the attachment of HMEC to BC surfaces, especially the RGD sequence. The images
obtained by scanning electron microscopy showed that the cells on the RGD-treated BC present a more
elongated morphology 48 h after cell seeding. The results also showed that RGD decreased the in-growth
of HMEC cells through the BC and stimulated the early formation of cord-like structures by these endo-
thelial cells. Thus, the use of recombinant proteins containing a CBM domain, with high afﬁnity and spec-
iﬁcity for cellulose surfaces allows control of the interaction of this material with cells. CBM may be
combined with virtually any biologically active protein for the modiﬁcation of cellulose-based materials,
for in vitro or in vivo applications.
 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction Many strategies have been pursued to improve the compatibil-Cardiovascular disease is the leading cause of mortality in Wes-
tern countries. Surgical bypass with autologous grafts remains the
most used treatment, saphenous veins and mammary arteries
being preferably used. However, many patients do not have suit-
able vessels, due to pre-existing vascular disease, amputation or
previous harvest for prior vascular procedures. Moreover, a second
surgical procedure is needed to obtain the vessel [1,2]. For the
reconstruction of arteries of large caliber currently available syn-
thetic grafts (e.g. Dacron, ePTFE and polyurethane) offer a reason-
able solution and proven clinical efﬁcacy. However, for small sized
(<6 mm) grafts these materials generally give poor performance,
due to anastomotic intimal hyperplasia and surface thrombogenic-
ity [3–5]. This scenario prompts the search for new materials suit-
able for the effective replacement of small blood vessels.
Bacterial cellulose (BC) produced by Acetobacter spp. is a bioma-
terial that has gained interest in the ﬁeld of tissue engineering due
to its unique properties. BC has been studied by several research
groups as a scaffold for cartilage [6–8], wound dressing [9,10], den-
tal implants [11–17], nerve regeneration [18,19] and vascular
grafts [18,20–23]. The in vivo biocompatibility of BC was also eval-
uated in a study conducted by Helenius and colleagues [24].ia Inc. Published by Elsevier Ltd. A
: +351 253 678986.
a).ity and effectiveness of vascular grafts, through the production of
unreactive surfaces, the surface modiﬁcation of existing synthetic
grafts (e.g. modifying surface properties and the incorporation of
biologically active substances) and coating with autologous cells
[4]. Seeding the graft surface with endothelial cells [25] is a prom-
ising approach; this mimicks the native vessel, thereby decreasing
thrombosis. However, the high loss of endothelial cells on the res-
toration of blood ﬂow after implantation presents a major chal-
lenge [4,26,27]. The rate and quality of endothelialization of a
synthetic vascular graft depends on the interaction of endothelial
cells with these cardiovascular materials. Several approaches have
been attempted to increase endothelial cell adhesion to typically
non-adhesive polymeric biomaterials used for synthetic vascular
grafts [28]. One such approach involves pre-coating with endothe-
lial cell-speciﬁc adhesives. The tripeptide Arg–Gly–Asp (RGD), an
amino acid sequence found in many adhesive plasma and extracel-
lular matrix proteins, has been used to enhance cell adherence.
Binding of cells to the RGD sequence occurs via integrin receptors
on the cell membrane. An improvement in the biocompatibility
and performance of BC – envisaging its use as small diameter vas-
cular grafts – by enhancing adhesion to human microvascular
endothelial cells (HMEC-1) was attempted in this work by coating
BC with adhesion peptides.
Many strategies have been developed to modify the materials
used as synthetic grafts (e.g. Dacron, ePTFE and polyurethane).
The adsorption of active substances like heparin, RGD, albumin–ll rights reserved.
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coatings being washed away [27]. In a previous work we described
the production of recombinant proteins containing adhesion se-
quences fused to a CBM (cellulose-binding module) [29]. For artiﬁ-
cial grafts based on cellulose the use of a CBM (exhibiting high
afﬁnity and speciﬁcity for cellulose surfaces) that can be combined
with virtually any biologically active protein is an important strat-
egy to avoid loss of the biological agents coating the graft.2. Materials and methods
2.1. Cell culture assays
Human microvascular endothelial cells (HMECs) (kindly pro-
vided by Dr. João NunoMoreira, Coimbra University) were used be-
tween passages 13 and 22. HMECs were cultured in RPMI 1640
medium (Invitrogen Life Technologies, UK) supplemented with
10% fetal bovine serum (FBS) (Invitrogen Life Technologies, UK),
1% penicillin/streptomycin (Invitrogen Life technologies, UK),
1.176 g l1 sodium bicarbonate, 4.76 g l1 HEPES, 1 ml l1 EGF
and 1 mg l1 hydrocortisone (>98% purity, Sigma, Portugal) and
maintained at 37 C in a humidiﬁed 5% CO2 atmosphere.
2.2. Cell attachment, proliferation and viability
2.2.1. Production and puriﬁcation of recombinant proteins
The recombinant peptides (RGD–CBM, RGD–CBM–RGD,
GRGDY–CBM, GRGDY–CBM–GRGDY) have been previously cloned
in Escherichia coli and their production and puriﬁcation were con-
ducted as previously described [29].
2.2.2. Production of bacterial cellulose and coating with the
recombinant peptides
Gluconacetobacter xylinus (ATCC 53582 and DSMZ 46604) pur-
chased from the American Type Culture Collection and from the
German Collection of Microorganisms and Cell Cultures were
grown in Hestrin–Schramm medium, pH 5.0. The medium was
inoculated with the culture, added to 24- or 96-well polystyrene
plates (1 or 0.2 ml per well, respectively) and incubated statically
at 30 C for 5 (ATCC 53582) or 10 days (DSMZ 46604). BC pellicles
were puriﬁed by 2% SDS treatment at 60 C for 12 h followed by 4%
NaOH at 60 C for 90 min. Samples were autoclaved and stored in
phosphate-buffered saline (PBS), pH 7.4, at 4 C prior to use. The
pellicles produced by the DSMZ 46604 strain (BC-L) had a thick-
ness of about 0.5 mm, while the pellicles produced by the ATCC
53582 strain (BC-H) were approximately 3 mm thick. The recombi-
nant proteins CBM and RGD–CBM (0.25 mg protein per membrane)
were left adsorbing to BC for 12 h at 4 C. Then, the membranes
were washed with PBS.
2.2.3. HMEC-1 adhesion and proliferation
The mitochondrial activity of the cultured cells was determined
using the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymeth-
oxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) colorimetric assay,
which is related to cell viability. BC-H or BC-L membranes treated
with the recombinant peptides were added to the wells of 24-well
polystyrene plates. The BC sheets were produced in similar 24-well
polystyrene plates, such that they ﬁtted tightly in the wells, com-
pletely covering the bottom surface. The HMEC-1 cells were seeded
on the BC at a density of 12  104 cells well1 in RPMI medium
without serum. The plates were incubated at 37 C in a 5% CO2,
95% humidiﬁed air atmosphere. Two hours after addition of the
cells the wells were washed with PBS and RPMI with 10% FBS
was added. MTS assay of the adsorbed HMEC-1 cells was carried
out to evaluate adhesion of the cells after 2 h and proliferation24 and 48 h and 7 days after cell seeding. The results were ob-
tained from at least three separate assays, each one done in
triplicates.
In order to evaluate the effect of RGD on the rate of cell adhe-
sion a similar assay was performed at 15, 30, 60, 90 and 120 min
after cell seeding, with the non-adherent cells being washed out
before carrying out the MTS assay.
2.2.4. Live and dead assay
The viability of the cells coating the cellulose (BC-L), treated or
not with the recombinant peptides, was also analyzed using a Live/
Dead viability/cytotoxicity kit for mammalian cells (Invitrogen,
UK). This kit provides a two-color ﬂuorescence cell viability assay,
based on the simultaneous determination of live and dead cells
with two probes that measure intracellular esterase activity and
plasma membrane integrity. This assay employs calcein, a polyan-
ionic dye, which is retained within living cells, producing a green
ﬂuorescence. It also employs an ethidium bromide homodimer
dye (red ﬂuorescence), which can enter the cells through damaged
membranes, binding to nucleic acids, but is excluded by the intact
plasmamembrane of living cells. The experiment was developed as
described for the MTS assay. Fluorescence microscopy observations
of the cells were carried out after 24 h incubation. Cells seeded on
polystyrene were used as a positive control (living cells), and cells
further treated with 70% methanol for 30 min were taken as a neg-
ative control (dead cells). The Live/Dead assay was also used to
determine apoptosis (qualitatively), in combination with the TUN-
EL assay (quantitatively). Samples were visualized and imaged
using an Olympus BX51 ﬂuorescence microscope (Olympus Portu-
gal SA, Porto, Portugal).
2.3. Morphological analysis by ﬂuorescence and scanning electron
microscopy (SEM)
BC-L membranes treated with recombinant peptides were
seeded with cells as previously described. For ﬂuorescence micros-
copy the membranes were washed with pre-warmed PBS 14 days
after cell seeding. Then the cells were ﬁxed in 4% formaldehyde
(Pierce, Rockford, IL) in PBS, permeabilized with acetone (Sigma)
at 20 C and stained with Alexa Fluor 546-phalloidin (Molecular
Probes). Nuclei were visualized by staining with DAPI. Microscopy
observations were performed using an Olympus BX51 (Olympus
Portugal SA) ﬂuorescence microscope. Fluorescence microscopic
observations were carried out only on the BC-L membranes, which
allowed proper visualization of the cells due to their thinness. For
SEM microscopy the medium was removed 48 h after cell seeding
and the BC pellicles were washed twice with PBS. Next, 1 ml of
2.5% glutaraldehyde in PBS was poured into each well and the
materials were maintained at room temperature for 1 h, in order
to ﬁx the cells on the membrane. Afterwards the membranes were
rinsed with distilled water, dehydrated by successive immersion in
a series of aqueous ethanol solutions (55, 70, 80, 90, 95 and 100
vol.%) for 30 min each, and allowed to evaporate at room temper-
ature. The surfaces of the membranes with adherent cells were ob-
served by SEM (Leica S360) after gold sputtering.
2.4. TUNEL assay for cell apoptosis
HMEC-1 cells (12  104 cells well1) were seeded on BC-L as de-
scribed for the MTS assay and after 24 h incubation the TUNEL (ter-
minal deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate nick-end labeling) assay, which examines DNA strand
breaks during apoptosis, was performed using an In Situ Cell Death
Detection kit (Roche Diagnostics, Basel, Switzerland), according to
the manufacturer’s instructions and as previously described [30].
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also stained with DAPI.2.5. Cell invasion
To evaluate the effect of RGD on the migration of endothelial
cells through the BC a migration chamber and an attractant were
used to stimulate cell growth into the BC. The migration chamber
consisted of cell culture inserts with a membrane pore size of
8.0 lm in a 24-well plate (BD Biocoat™ Matrigel™ Invasion Cham-
ber, BD Biosciences, Franklin Lakes, NJ). Initially, HMEC-1 cells
were seeded onto BC-L (treated with the recombinant peptides)
at a density of 2.5  104 cell well1 in RPMI medium without ser-
um. After 4 h 10% FBS was added to the wells. The plates were
incubated at 37 C in an atmosphere of 5% CO2 and 95% humidiﬁed
air for 24 h. The next day the cell-coated BC pellicles were trans-
ferred to the invasion chamber containing medium with 2% FBS.
To stimulate the cells to migrate into the cellulose 20% FBS were
added to the cell culture medium in the wells. Cell cultures were
incubated for 72 h. After the conclusion of the experiments the
Matrigel membranes were removed from the inserts with a scalpel.
The cellulose and Matrigel membranes were ﬁxed and stained with
methanol–DAPI solution and observed by ﬂuorescence microscopy.
The cells that migrated from the cellulose into the Matrigel were
counted.Fig. 1. MTS assays of HMEC-1 cultures on BC–H pellicles treated with the
recombinant proteins (CBM, RGD–CBM, RGD–CBM–RGD, GRGDY–CBM and2.6. Angiogenesis
BC-L pellicles produced in a 24-well polystyrene plate were
treated with the recombinant proteins and coated with HMEC cells
(4  104 cells well1) in serum-free medium for 2 h. Then 10% FBS
was added to the wells. The pellicles were incubated for 24 h at
37 C in an atmosphere of 5% CO2 and 95% humidiﬁed air. After-
wards the medium was removed and fresh medium with 10% ser-
um was added. The plates were incubated for 4 days. To evaluate
the effect of the recombinant peptides on the morphology and
assembly of endothelial cells into capillary-like structures when
cultured on BC pellicles, the cord-like structures were observed
qualitatively using a Leica DM IL inverted microscope (Leica Micro-
systems, Wetzlar, Germany).GRGDY–CBM–GRGDY) and buffer. The MTS assay was developed at 2, 24 and
48 h and 7 days after cell addition. Results are expressed as absorbance values at
490 nm.2.7. Immunocytochemistry
The cells were grown on BC treated with the recombinant pep-
tides (RGD–CBM or CBM) or buffer for 14 days, then ﬁxed with
methanol at 20 C. To avoid non-speciﬁc interactions the cellu-
lose membranes were blocked with 4% bovine serum albumin in
PBS. The primary antibody was von Willebrand factor (vWF)
(1:100) (Chemicon, Hofheim, Germany) and the secondary anti-
body FITC-conjugated anti-rabbit (1:1000) (Santa Cruz Biotechnol-
ogy, Santa Barbara, CA). The nuclei were counterstained with DAPI
(Sigma Aldrich, Portugal). Cells were observed by ﬂuorescent
microscopy (Nikon Eclipse 50i, Japan). The endothelial speciﬁcity
of the cells was also veriﬁed by the uptake of DiL-labelled acety-
lated low density lipoprotein (Biomedical Techologies, USA) an-
other speciﬁc marker for these cells.Fig. 2. MTS assays of HMEC-1 cultures on BC-L pellicles treated with the
recombinant proteins (CBM, RGD–CBM, RGD–CBM–RGD, GRGDY–CBM and
GRGDY–CBM–GRGDY) and buffer. The MTS assay was developed at 2, 24 and
48 h and 7 days after cell addition. Results are expressed as absorbance values at
490 nm.2.8. Statistical analyses
All experiments were performed in triplicate. Quantiﬁcations
are expressed as means ± SD of three independent experiments.
The statistical signiﬁcance of differences between various groups
were evaluated by one-way analysis of variance (ANOVA) followed
by the Bonferroni test.3. Results
The results of the MTS assay demonstrate that the recombinant
peptides containing adhesion sequences were able to signiﬁcantly
increase the attachment of HMEC to BC-H surfaces (Fig. 1). Two
hours after cell seeding approximately 140–150% and 60–80%
more cells adhered to BC treated with the peptides containing
the RGD and GRGDY sequences, respectively, when compared with
untreated BC-H. The results demonstrate that the peptides con-
taining RGD sequence had a stronger effect than the peptides con-
taining GRGDY sequences. Moreover, it seems that the presence of
a second adhesion sequence at the C-terminus did not signiﬁcantly
enhance the effect of the recombinant peptides when compared
with peptides containing only one copy of the sequence. Moreover,
the results indicate that adsorption of the CBM peptide on BC-H
slightly decreased cell adhesion (Fig. 1) by 14%. When the assay
was developed with BC-L membranes coated with peptides con-
taining one or two RGD copies approximately 108% and 77% more
cells adhered to the material than to untreated BC-L. The proteins
containing the GRGDY sequence promoted an increase of only 22–
40% in cell adhesion (Fig. 2). Fig. 3 shows that the improvement in
cell attachment was signiﬁcant as early as 15 min after cell seed-
Fig. 3. MTS assays of HMEC-1 cultures on BC-H pellicles treated with CBM, RGD–
CBM and buffer. The MTS test was developed at 15, 30, 60, 90 and 120 min after
addition of cells. Results are expressed as absorbance values at 490 nm.
Fig. 5. Apoptosis was quantitatively evaluated by the TUNEL assay. HMEC cells
were seeded on BC–L and after 24 h incubation a TUNEL assay was performed. Bars
represent the percentage of apoptotic cells evaluated by the ratio between TUNEL
stained cells and DAPI stained nuclei in each culture. Experiments were repeated
three times with identical results.
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ing (Figs. 1 and 2), irrespective of the BC membrane or treatment
used. However, after 7 days proliferation was noticeable on BC-H
treated with the RGD- and GRGDY-containing peptides (in contrast
to BC-H treated with CBM or buffer), while no proliferation was
visible when cells were cultured on BC-L.
To estimate the viability of cells on the protein-coated BC a Live/
Dead assay was performed 24 h after cell adhesion. The ﬂuores-
cence images obtained show that, irrespective of the treatment,
the cells remained viable on the BC pellicles (Fig. 4). The TUNEL as-
say results corroborated the Live/Dead assay, showing no signiﬁ-
cant differences between BC pellicles treated with the
recombinant peptides (RGD–CBM and CBM) when compared with
the control (buffer) (Fig. 5).
We next investigated whether RGD affected HMEC invasion
capacity using a double chamber assay. The cells were seeded on
the BC-L pellicle treated with the RGD or CBM sequence or buffer.
The number of migrating cells was then quantiﬁed through the
double chamber assay, using serum at 20% as a chemoattractant.
In comparison with the controls, RGD decreased the in-growth ofFig. 4. Fluorescence photographs of endothelial cells stained using a Live/Dead viability/
treated with (a) RGD–CBM, (b) CBM or (c) buffer. Controls contained (d) live and (e) deaHMEC cells through BC. Four and 2.4-fold increases in the number
of cells migrating through the membrane were obtained for the BC
treated with buffer and CBM, respectively, taking as a reference BC
treated with RGD (Fig. 6).
Optical microscopy indicated that RGD stimulated the forma-
tion of cellular cord-like structures at an earlier stage as compared
with the other groups. These ﬁndings showed that 24 h after seed-
ing most of the cells had a round shape in all groups (data no
shown). However, after 96 h the cells on the RGD-treated BC were
more elongated than those on the buffer control, starting to form
cord-like structures, while the cells in the CBM group remained
round shaped (Fig. 7). In fact, the structure shown in Fig. 7d, ob-
tained by ﬂuorescent microscopy, was found only on the BC sur-
faces treated with RGD. Details of the morphology of the cells
48 h after cell seeding were obtained by SEM. Cells on the RGD-
treated BC presented an elongated shape; in fact, as can be seen
in Fig. 8a, most of the cells were so elongated that they were hardly
noticeable by SEM, unlike cells observed on the untreated or CBM-cytotoxicity kit for mammalian cells. Live cells are stained green, dead cells red. BC-L
d cells on polystyrene. Images were acquired using a 40 objective (scale 50 lm).
Fig. 6. Effect of RGD on HMEC cell invasion of bacterial cellulose pellicles. Invasion
was quantiﬁed in a double chamber assay using medium complemented with 20%
FBS as a chemoattractant. Bars represent the number of invasive cells.
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widely used criterion in deﬁning the endothelial cell phenotype
[31–33], thus to determine whether HMECs maintain this endothe-
lial phenotype characteristic after 14 days culture on BC vWF
expression was evaluated. The immunocytochemistry results show
that cells grown on BC treated with the recombinant peptides or
buffer maintained their positive staining for vWF (Fig. 9).4. Discussion
G. xylinus constructs a BC pellicle with a denser and ﬂatter sur-
face on one side and a gelatinous layer on the other [18]. In this
study all the experiments were conducted on the denser side of
both BC-H and BC-L, because a smooth surface, being similar to
the basal membrane of the luminal side of blood vessels, is prefer-
able for the attachment of endothelial cells [20]. Analysis by SEMFig. 7. (a–c) Optical micrographs showing the effect of RGD on the assembly of endothel
buffer. Images were acquired using a 20 objective (scale 200 lm). (d) Fluorescent micro
RGD–CBM recombinant protein. Nuclei were visualized by staining with DAPI (blue) an
objective (scale 100 lm).showed that G. xylinus ATCC 53582 produced a thicker and more
compact cellulose pellicle than strain DSMZ 46604 (data not
shown). Therefore, the BC-H pellicle presents a smoother surface
than BC-L. This may lead to differences between BC-H and BC-L
in the adhesion and proliferation of cells in the MTS test. The re-
sults of the attachment assay were similar to those obtained in
our previous work, when ﬁbroblasts were seeded on BC produced
by strain ATCC 53582 coated with adhesion peptides [29]. In that
previous work RGD improved the adhesion of ﬁbroblasts to cellu-
lose, while the presence of a second RGD did not enhance the effect
of the recombinant peptide, probably because the RGD sequence at
the C-terminus of the peptide was not exposed in such a way as to
be recognized by integrins. However, unlike the results with endo-
thelial cells, the GRGDY sequence had no effect on the adhesion of
ﬁbroblasts. Apparently, microvascular endothelial cells adhere
more strongly than ﬁbroblasts to recombinant peptides containing
RGD sequences. Indeed, endothelial cells may have substantially
more avb3 integrin than ﬁbroblasts [34]. The results also demon-
strate that pre-coating BC with the RGD-containing peptides de-
creased the incubation time required for adsorption. A short
incubation period is particularly important in single stage seeding
as the incubation time is kept to a minimum to ﬁt within the time
frame of the surgical procedure [26].
Several works have been developed to improve the interaction
of cells with BC [21,29,35,36]. However, only a few have studied
the migration and in-growth of cells on BC [20,21,6,37]. The migra-
tion of cells is mainly mediated by integrins, a diverse family of
glycoproteins that form heterodimeric receptors for extracellular
matrix (ECM) molecules. During migration cells project lamellipo-
dia that attach to the ECM and simultaneously break existing ECM
contacts at their trailing edge. This allows the cell to pull itself for-
ward. Integrins are essential for cell migration and invasion, not
only because they directly mediate adhesion to the ECM, but also
because they regulate intracellular signaling pathways that control
cytoskeleton organization, force generation, gene transcription and
survival [38].
Endothelialization may either be developed ex vivo or post-
implantation, stimulating endothelial cells (from tissues adjacential cells into capillary-like structures: (a) BC-L treated with RGD–CBM; (b) CBM; (c)
scopy image showing HMECs cells cultured for 14 days on BC-L pellicles treated with
d F-actin with Alexa Fluor 546-phalloidin (red). Images were acquired using a 20
Fig. 8. SEM micrographs of bacterial cellulose. BC treated with: (a and b) RGD–CBM; (c and d) CBM; (e and f) buffer. The arrows mark cells with an elongated morphology. (a,
c, and e) Scale 50 lm; (b, d, and f) scale 5 lm.
Fig. 9. Immunocytochemical analyses using anti-vWF antibody. The results showed that HMEC cells cultured for 14 days on BC-L treated with recombinant proteins or buffer
stained positively for vWF: (a) RGD–CBM; (b) CBM; (c) buffer. Images were acquired using a 20 objective (scale 100 lm).
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ate on the graft. The rate and quality of vascular graft endothelial-
ization depends on cell–material interaction, leading to such as
adhesion and migration. Several studies have shown that cell
adhesiveness to the substratum modulates cell migration on sur-
faces coated with ECM proteins [25,39–41]. Our results have
shown that a small number of cells migrated through the cellulose
when compared with the rather large number of cells added
(2.5  104 cells well1). During invasion cells release proteases that
degrade and remodel the ECM, promoting cell passage through to
the stroma and entrance into the new tissue [38]. However, animal
cells cannot degrade cellulose [24] and in order to migrate in a ﬁ-
brous hydrogel such as BC the cells must push the nanoﬁbrils aside
when migrating into the cellulose network [20]. Probably the time
course of the experiment (72 h) was too short to enable cells to mi-
grate through a BC pellicle of 0.5 mm thickness. Nevertheless, the
results obtained allow the observation that the migration of endo-
thelial cells on BC was decreased by the presence of RGD. Since
adhesion involves receptor/ligand binding, cell migration can be
regulated by controlling cell integrin expression, integrin–ECM
binding afﬁnity or substratum ECM surface density. However, if
other stimuli are added, such as growth factors that affect signaling
processes of the cell, the migration/adhesion relationship can be
dramatically altered [42,43]. The migration rates of cells are inﬂu-
enced by chemical and physical interaction with the surface of the
material. Previous research has shown that cell migration capacity
presents a biphasic behavior depending on the attachment
strength. Optimal migration speed can be achieved with interme-diate strengths of adhesiveness, since when adhesion to the sub-
stratum is weak no traction occurs, so that movement is
impossible and the cell spreads poorly. On the other hand, with
strong adhesion the cell is well-spread and immobilized, so dy-
namic disruption of cell–substratum attachments is difﬁcult and
movement again does not occur [28,39,40,44,45]. The CBM used
in this work had a high afﬁnity for cellulose and was adsorbed in
a speciﬁc and very stable way. Probably the amount of protein used
in the experiments was enough to saturate the surface of the cellu-
lose pellicle with RGD-containing peptides, resulting in a very high
afﬁnity of the cells for the substratum and negatively affecting
migration through the BC. Saturation of the surface of the cellulose
pellicle with RGD-containg peptides is corroborated by the results
of our previous work [29]. In order to enhance endothelialization of
BC vascular grafts it is important to promote not only the adhesion
of endothelial cells, but also to allow migration through the mate-
rial. The treatment used in this work greatly improved adhesion,
however, migration was negatively affected by the presence of
RGD, because the afﬁnity of HMECs for the material surface be-
came to strong. However, it is probably possible to improve migra-
tion of the cells on BC by optimizing the concentration of RGD-
containing peptide, in an attempt to reach a compromise between
adsorption and migration. However, longer experiments are
needed to better assess the effect of RGD on cell migration through
BC.
The effect of RGD on HMEC morphology was observed by
SEM. The cells on the RGD-coated BC exhibited a more elon-
gated, ﬂattened morphology, while those on ‘‘bare” BC were
4040 F.K. Andrade et al. / Acta Biomaterialia 6 (2010) 4034–4041round (Fig. 8a and b). The more extended morphology of HMECs
upon interaction with the adhesive peptides is likely driven by
the greater number of focal contacts between integrins and
RGD-containing peptides linked to the BC surface. It is well
known that a critical RGD density is essential for the establish-
ment of mature and stable integrin adhesions, which, in turn, in-
duce efﬁcient cell migration, spreading and formation of focal
adhesions [46–49].
During angiogenesis cells must adhere to one another and to
the ECM to construct and extend new microvessels [50]. Angiogen-
esis depends not only on growth factors and their receptors, but is
also inﬂuenced by receptors for ECM proteins. Our results show
that the RGD-containing recombinant peptide (RGD–CBM) stimu-
lated the early formation of cellular cord-like structures on BC
when compared with BC treated with a recombinant peptide with-
out the adhesion sequence (CBM) or buffer. HMEC-1 cells express
aVb3 and aVb5 integrins [51] that can bind an array of ligands, such
as vitronectin, ﬁbronectin, vWF, ﬁbrinogen, osteopontin, thrombo-
spondin and RGD-containing peptides [50,52]. Moreover, these
two complexes have also been identiﬁed as having an especially
interesting expression pattern among vascular cells during angio-
genesis and vascular remodeling.
Immunocytochemistry results showed that cells grown on BC
maintained their positive staining for vWF. This glycoprotein is
one of the various secretory and membrane-bound molecules pro-
duced by the endothelium. vWF mediates the interaction of plate-
lets with damaged endothelial surfaces at sites of vascular injury
and has long been favored as an endothelial cell marker, with
expression of this factor being highly restricted to endothelial cells,
platelets and megakaryocytes [33].
In the current scenario of regenerative medicine there is a great
demand for the production of new materials appropriate for small
diameter blood vessel replacements. In this work BC, a promising
cardiovascular biomaterial, was successfully functionalized. The
strategy used was aimed at improving microvascular cell adhesion
to BC, through recombinant peptides containing adhesion se-
quences and a CBM. For artiﬁcial grafts based on cellulose the
use of a CBM (exhibiting a high afﬁnity and speciﬁcity for cellulose
surfaces) is an excellent feature, as a CBM can be combined with
virtually any biologically active protein and used to modify cellu-
lose-based materials. The chimeric peptides were able to enhance
endothelial cell adhesion to BC and stimulate angiogenesis. How-
ever, the in-growth of cells into cellulose was decreased. We be-
lieve that improved migration of the cells on BC will be achieved
with intermediary concentrations of the peptides used in this
work.
Acknowledgements
F.K.A. is the recipient of a fellowship from Coordenação de Aper-
feiçoamento de Pessoal de Nível Superior (CAPES, Brazil). This re-
search was supported by Fundação para a Ciência e Tecnologia
under a POCTI program.Appendix A. Figures with essential colour discrimination
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ﬁcult to interpret in black and white. The full colour images can be
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